bta - half yearly fin.results, page-6

why the interest in the half year report, nothing happening in that time, they had heaps in the bank from the spp, and no sales of relenza because its not reported until May from GSK, other funds from the partnership with the other product
I think you are kidding yourselves if you think it can be a bad report, just normal costs and more money in the bank
the full yearly after GSk pay up and money due then is what you should be interested in, and the sp will rise prior to that alone
geeez